Rockville, Md. -- The proceedings from the second annual ARVO/Pfizer Ophthalmics Research Institute conference, "Aqueous Humor Outflow: What Do We Know? Where Will It Lead Us?" were published today in ...

Increased intraocular pressure (IOP) represents a major risk factor for glaucoma, a prevalent eye disease characterized by death of retinal ganglion cells; lowering IOP is the only proven treatment ...

Please provide your email address to receive an email when new articles are posted on . Microinvasive glaucoma surgery, an alternative to trabeculectomy and tube shunt implantation, is designed to ...

Glaucoma—the leading cause of vision loss worldwide—includes a heterogeneous group of disorders. Primary open-angle glaucoma (POAG) and exfoliation glaucoma (XFG) are linked to decreased outflow of ...

RUDN University doctors have proposed an alternative method of surgical management of glaucoma. The main risk factor of glaucoma is increased pressure in the eye. To reduce it doctors proposed to ...

WELLESLEY, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc. (the “Company” or “Qlaris”), a biotechnology company targeting high unmet needs in debilitating ophthalmic diseases, today announced results from QC ...

Please provide your email address to receive an email when new articles are posted on . “It is the first and only device shunting the aqueous to a location that is not the subconjunctival space, nor ...

Biologists have found an explanation for the increase in intraocular pressure in glaucoma and a promising therapeutic option to rejuvenate the eye. Researchers at the Center for Vascular Research, ...

A new study in mice has identified new treatment targets for glaucoma, including preventing a severe pediatric form of glaucoma, as well as uncovering a possible new class of therapy for the most ...

Researchers at the Center for Vascular Research, within the Institute for Basic Science (IBS), have identified a new mechanism involved in the development and progression of glaucoma, and found a ...